Menu
Back to Journals » Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
Editor-in-Chief: Professor Garry Walsh
ISSN 1176-6336 (Print) - went to online only in 2009
An international, peer-reviewed open access journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (2343)
- Volume 20, 2024 (35)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Latest articles:
- 5 records -
A Nomogram Based on Clinicopathological Characteristics for Estimating the Risk of Brain Metastasis from Advanced Gastric Cancer: A Multi-Center Retrospective Clinical Study
Zhang L, Yu Z, Zhang Y, Wang H, Cheng J, Shi C
Therapeutics and Clinical Risk Management 2024, 20:391-404
Published Date: 24 June 2024
Experiential Learning with Ketamine: A Mixed-Methods Exploratory Study on Prescription and Perception
Ilg AM, Beltran CP, Shih JA, Yankama TT, Hayes MM, Moskowitz AL
Therapeutics and Clinical Risk Management 2024, 20:381-390
Published Date: 21 June 2024
Resilience in Rectal Cancer Treatment: Lessons from the COVID-19 Era in Czech Republic
Ihnát P, Martínek L, Tulinský L, Kala Z, Grolich T, Gurlich R, Šturma J, Klos D, Špička P, Neoral Č, Černý V
Therapeutics and Clinical Risk Management 2024, 20:373-379
Published Date: 17 June 2024
The Use of Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio and Platelets-to-Lymphocyte Ratio in the Assessment of the Risk of Conversion and Complications After Cholecystectomy Performed Due to Symptomatic Cholelithiasis
Molasy B, Frydrych M, Kubala-Kukuś A, Głuszek S
Therapeutics and Clinical Risk Management 2024, 20:363-371
Published Date: 15 June 2024
A Prospective Longitudinal Cohort Study of Serum Stanniocalcin-1 as a Potential Prognostic Biomarker of Severe Traumatic Brain Injury
Jin C, Huang X, Hu Y, Xu B, Ma J
Therapeutics and Clinical Risk Management 2024, 20:341-361
Published Date: 11 June 2024